Psychedelics Therapy

Editor's Note: A prior version of this article was erroneously attributed to a different author. The article was written by Mattha Busby and originally published on DoubleBlind Mag. The article has been updated to reflect the appropriate byline and full content of the original...

Recent advancements in understanding mental health and the brain have allowed us to identify possible commonalities between different mental health conditions. One of the shared experiences among patients with conditions like treatment-resistant depression (TRD), bipolar II disorder and PTSD is the...

Nora Volkow, the director of the National Institute on Drug Abuse (NIDA), said that psychedelic substances have promising potential for therapeutic uses, particularly for treating severe depression, post-traumatic stress disorder (PTSD) and addiction. Accelerating Research At a...

Specialty pharmaceutical company PharmaTher Holdings (OTCQB: PHRRF) has submitted a Fast Track Application to the Food and Drug Administration (FDA) for KETARX, a ketamine drug that may help treat levodopa-induced dyskinesia in Parkinson’s disease. Fast Track designation is for...

Grammy-winning musician and producer Wyclef Jean spoke to journalist Javier Hasse for Forbes about his cannabis use, its relationship to hip-hop culture and his involvement in the cannabis industry. Cannabis: A Journey to Creativity, Focus And Advocacy Jean started using...

Australia has announced that it will become the first country in the world to reschedule the medical use of MDMA and Psilocybin, two key ingredients in psychedelic drugs. On Feb. 3, the Therapeutic Goods Administration (TGA) revealed that these substances would be moved from Schedule 9, which...

The University of Exeter is launching a new postgraduate program on psychedelics, called "Psychedelics: Mind, Medicine, and Culture." The program aims to train therapists, mental health advocates, and healthcare workers on how to safely work with psilocybin, LSD, MDMA, and other...

Activists held a protest, including a die-in outside of the Drug Enforcement Administration (DEA) headquarters in Virginia. They were protesting against the DEA's “obstruction of Right to Try statutes at the federal and state level that patients and advocates say should...

Dr. Bronner's, the family-owned maker of one of America’s favorite soaps, has expanded its mental healthcare benefits to include Ketamine Assisted Therapy as a first step in providing access to Psychedelic Assisted Therapy to employees as a way of promoting mental health....

Cybin Inc (NYSE: CYBN), a Toronto-based biotechnology company focused on utilizing psychedelic drugs as an alternative to traditional psychiatric drugs, announced positive pre-clinical data, indicating that its drug, CYB003 showed strong signs of cognitive improvement in patients with Major...